Secor Alicia

Director at ZEVRA THERAPEUTICS, INC. · on record since Dec 9, 2025
Director at G1 Therapeutics, Inc. · on record since Jun 21, 2021
SVP, Chief Operating Officer at SYNAGEVA BIOPHARMA CORP · on record since Sep 23, 2013
Chief Commercial Officer at Larimar Therapeutics, Inc. · on record since Jun 23, 2014
Director at JUNIPER PHARMACEUTICALS INC · on record since Aug 29, 2016
President and CEO at JUNIPER PHARMACEUTICALS INC · on record since Aug 29, 2016
Director at GW PHARMACEUTICALS PLC · on record since Oct 1, 2018
Director at Orchard Therapeutics plc · on record since Jan 2, 2020

Insider trading activity of Secor Alicia

Transactions on record: 64; since Sep 23, 2013

Open-market buys: 2; $108.8K

Open-market sells: 5; $1.1M

Companies traded: 7; last filing Jun 18, 2026

Figures computed from official regulatory filings — .

Companies where Secor Alicia has traded

ZEVRA THERAPEUTICS, INC.2 tx · Jun 18, 2026
G1 Therapeutics, Inc.12 tx · Sep 18, 2024
Orchard Therapeutics plc6 tx · Jan 24, 2024
GW PHARMACEUTICALS PLC23 tx · $73K · May 7, 2021
JUNIPER PHARMACEUTICALS INC12 tx · $1.3M · Aug 15, 2018
Larimar Therapeutics, Inc.8 tx · $1.4M · Apr 4, 2016
SYNAGEVA BIOPHARMA CORP1 tx · Sep 23, 2013

Track record of Secor Alicia

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Secor Alicia

Co-insiders of Secor Alicia

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
ZEVRA THERAPEUTICS, INC.Listing on record	Jun 18, 2026	AwardD (derivative)	30,000	0.00 USD	—	SEC
ZEVRA THERAPEUTICS, INC.Listing on record	Dec 9, 2025	AwardD (derivative)	45,000	0.00 USD	—	SEC
G1 Therapeutics, Inc.Listing unverified	Sep 18, 2024	OtherD (derivative)	-30,000	—	—	SEC
G1 Therapeutics, Inc.Listing unverified	Sep 18, 2024	Other	-10,000	—	—	SEC
G1 Therapeutics, Inc.Listing unverified	Sep 18, 2024	Other	-20,000	—	—	SEC
G1 Therapeutics, Inc.Listing unverified	Sep 18, 2024	OtherD (derivative)	-30,000	—	—	SEC
G1 Therapeutics, Inc.Listing unverified	Sep 18, 2024	OtherD (derivative)	-30,000	—	—	SEC
G1 Therapeutics, Inc.Listing unverified	Jun 14, 2024	AwardD (derivative)	30,000	0.00 USD	—	SEC
G1 Therapeutics, Inc.Listing unverified	Jun 14, 2024	Award	10,000	0.00 USD	—	SEC
Orchard Therapeutics plcListing unverified	Jan 24, 2024	OtherD (derivative)	-46,000	0.00 USD	—	SEC
Orchard Therapeutics plcListing unverified	Jan 24, 2024	OtherD (derivative)	-105,000	0.00 USD	—	SEC
G1 Therapeutics, Inc.Listing unverified	Jun 16, 2023	Award	10,000	0.00 USD	—	SEC
Orchard Therapeutics plcListing unverified	Jun 16, 2023	AwardD (derivative)	105,000	0.00 USD	—	SEC
G1 Therapeutics, Inc.Listing unverified	Jun 16, 2023	AwardD (derivative)	30,000	0.00 USD	—	SEC
G1 Therapeutics, Inc.Listing unverified	Jun 24, 2022	Award	10,000	0.00 USD	—	SEC
G1 Therapeutics, Inc.Listing unverified	Jun 24, 2022	AwardD (derivative)	30,000	0.00 USD	—	SEC
Orchard Therapeutics plcListing unverified	Jun 8, 2022	AwardD (derivative)	46,000	0.00 USD	—	SEC
G1 Therapeutics, Inc.Listing unverified	Jun 21, 2021	AwardD (derivative)	52,320	0.00 USD	—	SEC
Orchard Therapeutics plcListing unverified	Jun 17, 2021	AwardD (derivative)	40,000	0.00 USD	—	SEC
GW PHARMACEUTICALS PLCListing unverified	May 7, 2021	Other	-10,584	—	—	SEC
GW PHARMACEUTICALS PLCListing unverified	May 7, 2021	OtherD (derivative)	-35,340	—	—	SEC
GW PHARMACEUTICALS PLCListing unverified	May 7, 2021	OtherD (derivative)	-22,464	—	—	SEC
GW PHARMACEUTICALS PLCListing unverified	May 7, 2021	OtherD (derivative)	-16,548	—	—	SEC
GW PHARMACEUTICALS PLCListing unverified	May 7, 2021	OtherD (derivative)	-3,144	—	—	SEC
GW PHARMACEUTICALS PLCListing unverified	May 7, 2021	OtherD (derivative)	-34,416	—	—	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
ZEVRA THERAPEUTICS, INC.Listing on record	Jun 18, 2026	AwardD (derivative)	30,000	0.00 USD	—	SEC
ZEVRA THERAPEUTICS, INC.Listing on record	Dec 9, 2025	AwardD (derivative)	45,000	0.00 USD	—	SEC
G1 Therapeutics, Inc.Listing unverified	Sep 18, 2024	OtherD (derivative)	-30,000	—	—	SEC
G1 Therapeutics, Inc.Listing unverified	Sep 18, 2024	Other	-10,000	—	—	SEC
G1 Therapeutics, Inc.Listing unverified	Sep 18, 2024	Other	-20,000	—	—	SEC
G1 Therapeutics, Inc.Listing unverified	Sep 18, 2024	OtherD (derivative)	-30,000	—	—	SEC
G1 Therapeutics, Inc.Listing unverified	Sep 18, 2024	OtherD (derivative)	-30,000	—	—	SEC
G1 Therapeutics, Inc.Listing unverified	Jun 14, 2024	AwardD (derivative)	30,000	0.00 USD	—	SEC
G1 Therapeutics, Inc.Listing unverified	Jun 14, 2024	Award	10,000	0.00 USD	—	SEC
Orchard Therapeutics plcListing unverified	Jan 24, 2024	OtherD (derivative)	-46,000	0.00 USD	—	SEC
Orchard Therapeutics plcListing unverified	Jan 24, 2024	OtherD (derivative)	-105,000	0.00 USD	—	SEC
G1 Therapeutics, Inc.Listing unverified	Jun 16, 2023	Award	10,000	0.00 USD	—	SEC
Orchard Therapeutics plcListing unverified	Jun 16, 2023	AwardD (derivative)	105,000	0.00 USD	—	SEC
G1 Therapeutics, Inc.Listing unverified	Jun 16, 2023	AwardD (derivative)	30,000	0.00 USD	—	SEC
G1 Therapeutics, Inc.Listing unverified	Jun 24, 2022	Award	10,000	0.00 USD	—	SEC
G1 Therapeutics, Inc.Listing unverified	Jun 24, 2022	AwardD (derivative)	30,000	0.00 USD	—	SEC
Orchard Therapeutics plcListing unverified	Jun 8, 2022	AwardD (derivative)	46,000	0.00 USD	—	SEC
G1 Therapeutics, Inc.Listing unverified	Jun 21, 2021	AwardD (derivative)	52,320	0.00 USD	—	SEC
Orchard Therapeutics plcListing unverified	Jun 17, 2021	AwardD (derivative)	40,000	0.00 USD	—	SEC
GW PHARMACEUTICALS PLCListing unverified	May 7, 2021	Other	-10,584	—	—	SEC
GW PHARMACEUTICALS PLCListing unverified	May 7, 2021	OtherD (derivative)	-35,340	—	—	SEC
GW PHARMACEUTICALS PLCListing unverified	May 7, 2021	OtherD (derivative)	-22,464	—	—	SEC
GW PHARMACEUTICALS PLCListing unverified	May 7, 2021	OtherD (derivative)	-16,548	—	—	SEC
GW PHARMACEUTICALS PLCListing unverified	May 7, 2021	OtherD (derivative)	-3,144	—	—	SEC
GW PHARMACEUTICALS PLCListing unverified	May 7, 2021	OtherD (derivative)	-34,416	—	—	SEC